We work closely with malaria experts locally and globally on the many different issues and opportunities linked to fighting the disease. Our key Policy Advisors bring expansive knowledge and exceptional experience to help guide our work and investments to end malaria deaths in Africa.
Alan is Senior Advisor to our co-founder Ray Chambers, the UN Special Envoy for the Financing of the Health MDGs and for Malaria. Before joining the UNSE office, Alan was the Director of the UNICEF Programme Division with postings in Latin America, Africa and South Asia. As the Director of the UNICEF Programme Division, he led the division’s strategy development, programme guidance and implementation processes and was responsible for seeing UNICEF’s programs were focused on the achievement of the Millennium Development Goals. Prior to this, Alan served for five years as Director of the UNICEF Supply Division in Copenhagen. Before these roles, Alan had a long and distinguished career in the field.
Professor Sir Richard Feachem
Sir Richard is Professor of Global Health at the University of California, San Francisco and the University of California, Berkeley, and Director of the Global Health Group at UCSF Global Health Sciences. From 2002 to 2007, Richard served as founding Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria and Under Secretary General of the United Nations. Previously, Dr. Feachem was Director of Health, Nutrition and Population at the World Bank (1995-1999), and Dean of the London School of Hygiene and Tropical Medicine (1989-1995). Sir Richard has worked in international health and development for 40 years and has published extensively on public health, health policy and development finance. Richard is on the Board of Malaria No More US and one of the world’s foremost experts on malaria elimination.
Professor David Schellenberg
David is Professor of Malaria & International Health at the London School of Hygiene and Tropical Medicine (LSHTM). He has degrees in clinical science and medicine from the University of London, followed by a DTM&H from Liverpool, MRCP in London and PhD from the University of Barcelona, Spain. David was based at the Ifakara Health Institute, Tanzania, between 1995-2001 then again 2004-2007, working on various descriptive and intervention studies relating to child health, especially malaria. David has worked extensively on Intermittent Preventive malaria Treatment for the control of malaria and anaemia in Infants (IPTi) and in 2003 David joined the LSHTM to help build the IPTi Consortium, before returning to Tanzania in 2004 to work on a large-scale evaluation of the effectiveness of IPTi. David been based in London since the end of 2007. Since 2009 he has been Director of the ACT Consortium, answering key questions on malaria drug delivery. David is deputy director of the Malaria Capacity Development Consortium, which works to strengthen capacity for health research in Africa. He supports the Malaria Vaccine Initiative in the clinical evaluation of RTSs, the most advanced malaria vaccine candidate. He also has a powerful personal experience of malaria as two of his sons suffered from the disease.
Professor Bob Snow
Bob is Professor of Tropical Public Health at the University of Oxford and head of the Malaria Public Health and Epidemiology Group (MPHEG) in Nairobi, Kenya. His work began with the first clinical trials of Insecticide-treated bed nets in The Gambia and he has since developed a large programme of work on the public health burden of malaria in Africa and understanding ways in which this can be reduced through scientifically proven methods of intervention, effective partnerships with African governments and appropriate financing. He has worked in Africa for the last 22 years and published over 300 articles on malaria, is a technical advisor to the Kenyan Government and sits on a number of international malaria advisory panels. He is supported by the Wellcome Trust (UK) as a Principal Fellow and lives in Nairobi where he oversees the MAP project along with the wider operational research agenda of the MPHEG.
All our Policy Advisors are available for media interviews. Please email email@example.com or call 020 7801 3840.